Results

Total Results: 199 records

Showing results for "end stage renal".

81. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
    August 23, 2012 - TENS is only used for first stage labor. … third stage boxes. … labor, length of second-stage labor, and length of third- stage labor. … Section Comment Response Reviewer #11 Results Biochemical Findings, p. 58: Since the main data are re renal … Footnotes are listed at the end of each table.

82. Meeting Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
    January 01, 2011 - Collaborating with patient and consumer representatives at each stage in the research process improves … Toward that end, the expected role and required training of representatives should be clearly established … Presenting a clear timeline and anticipated time commitment at each stage of the project is also … Collyar President, Patient Advocates in Research (PAIR) Virna Elly Patient Advocate, Mid-Atlantic Renal

83. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
    January 30, 2012 - We will monitor the number of articles excluded at the abstract stage for English language and determine … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

84. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
    August 01, 2012 - Informants included representatives from the American Association for Clinical Chemistry; experts in renal … The other study, of C quality, compared the SFLC ratio with clinical stage (per Durie– Salmon staging … from already diagnosed patients could potentially bias the evidence, as they reflect the extreme end … reporting standards and a paucity of information regarding high-risk subgroups such as patients with renal … Serum free light chain measurements move to center stage.

85. AHRQ's Evidence-based Practice Center Division Annual Report 2020: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2020.pdf
    January 01, 2020 - End-stage Renal Disease in the Medicare Population: Frequency and Duration of Hemodialysis and Quality … Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease … Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer.

86. Systematic Review of Calcineurin Inhibitors for Kidney Transplant | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research-protocol

87. Vte-Prophyalaxis Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - failure, chronic renal failure, or end-stage renal disease. 22-25 Some of these patient groups have … impairment, or severe renal impairment not undergoing dialysis and patients receiving dialysis? … impairment, severe renal impairment, and renal replacement therapy (KQ 8) Special Populations (Timing … impairment, severe renal impairment, renal replacement therapy • Animal studies/models • Children … CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

88. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - Page 32, line 45: Missing “placebo” from the end of the first sentence. … Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal … Public Comment #3 (APA) Introduction p. 4 table disulfiram Suggest changing "at the acetaldehyde stage

89. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - in 2-3 doses; Extended- release, 100-200 mg/day RA: Delayed- release, 100-200 mg/day in 3- 4 Renal … impairment(CrCl >25 mL/min) max 150 mg/day; Moderate renal impairment (CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal endpoint or serious liver AEs. … update 9/16/02 Pain reduction 2 placebo controlled trials provided pain intensity at baseline and end

90. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated … Many surrogate/intermediate end points have not been adequately validated. … Just because there is enough information to pool a myriad of intermediate end points does not mean that … This completes the topic refinement project and sets the stage for the next phase, in which the key questions

91. Measuring-Blood-Pressure Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
    January 01, 2012 - One quality C study reported on mortality and end-stage renal disease. … lower mortality with SMBP plus self- titration versus usual care, and lower composite mortality and end-stage … renal disease. … End-stage renal disease alone was not significantly different.

92. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - population includes patients for whom treatment is contraindicated:  Pregnant women  Patients with renal … We will code the reason any articles, at the stage of the full-text review, are not included in the … Studies at the abstract and full-review stage will be managed with Reference Manager so that we can … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … population include patients for whom treatment is contraindicated:  Pregnant women  Patients with renal

93. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - payers have also broadened the eligibility for treatment to include infected individuals with earlier stage … Lymphomas Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders Catheter-Based Renal … some third-party payers is to treat only those patients in advanced 10 stages of infection (stage … When added to standard intraoperative assessment during lumpectomy for early stage breast cancer, MarginProbe … Care System for Preserving Donor Lungs A double-lung transplant is a last resort for patients with end-stage

94. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
    November 19, 2009 - For example, intact parathyroid hormone (PTH) measurements are used to manage patients with renal osteodystrophy … Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage … renal disease patients: implication for treatment decisions.

95. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - 79 202 1 26 1 141 261 1 26 8 186 262 1 27 1 8 326 1 27 8 5 327 1 28 4 53 116 4 28 7 50 112 4 END … 1 1 7 NA 2 141 261 186 262 NA 1 1 8 NA 2 8 326 5 327 NA 1 1 8 NA 2 53 116 50 112 NA 1 4 7 NA 2 END … array x[3] x1-x3; do i=1 to 3; if i<= narm then x[i]=sqrt(0.5)*((i=index)-1/narm); else x[i]=0; end … RCT USA N: 413 Stage ≥3 pelvic organ prolapse, history of lower urinary tract surgery, lifelong … diabetes mellitus, demand cardiac pacemaker or intrauterine device use, genital prolapse greater than Stage

96. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
    November 20, 2013 - Rev 3 disc The decision to emphasize BMI and renal function as potential confounders of the diagnostic … The AHRQ report in 2006 identified both renal function and weight as potential physiological variables … Prognostic value of high sensitivity C-reactive protein, N- terminal proBNP, and cardiac troponin T and I in end … stage renal disease for subsequent death over two years. … Furthermore, at this stage of development, it is unlikely that more research as suggested under research

97. Gout Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - Identify the existing systematic reviews and make a judgment about relevancy for the KQs, the end date … Both colchicine and NSAIDs require dose reduction in renal impairment. … Description and guidelines for prevention in patients with renal insufficiency. … Allopurinol-induced severe hypersensitivity with acute renal failure. … A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.

98. skin-cancer-protocol-160810 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
    August 10, 2016 - People with a limited life expectancy (e.g., the very elderly, those with terminal cancer, those with end … stage renal disease) • Subgroups defined by location or grade of lesion are also of interest: o Location … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end users, individuals are invited to serve as Key Informants and those who

99. Making Healthcare Safer IV Rapid Review: Examining the Impact of Implementing High-Reliability Organization Principles on Patient Safety Outcomes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
    May 01, 2025 - o AHRQ Safety Program for End-Stage Renal Disease Facilities33: a toolkit to help end-stage renal disease … member checked a 10 percent sample of excluded citations at both the title/abstract and full text stage … AHRQ Safety Program for End-Stage Renal Disease Facilities – Toolkit. … Evidence-based Practice Center (EPC) Program is developing a range of rapid evidence products to assist end-users

100. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
     August 27, 2012 - Before we begin I would like to set the stage for why we felt this was an important webcast to host. … minutes at the end. … I will be discussing the use of analytic hierarchy process, the stage of which was set very nicely … The gain for going from five months to ten months in progression free survival in renal cell carcinoma … specific question for you, Reed, is how do you manage to get patient input on things like treatment for renal